| Authors: |
Volpi CR; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: cvolpi@ihv.umaryland.edu., Chama J; Institute of Human Virology Nigeria, Abuja, Nigeria., Adebiyi R; Institute of Human Virology Nigeria, Abuja, Nigeria., Aigoro JA; Institute of Human Virology Nigeria, Abuja, Nigeria., Bawa YJ; Institute of Human Virology Nigeria, Abuja, Nigeria., Kolawole KE; Institute of Human Virology Nigeria, Abuja, Nigeria., Ononaku U; Institute of Human Virology Nigeria, Abuja, Nigeria., Ayuba N; Institute of Human Virology Nigeria, Abuja, Nigeria., Shutt A; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA., Aka A; International Centre for Advocacy on Rights to Health, Abuja, Nigeria., Goldstone SE; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Dakum P; Institute of Human Virology Nigeria, Abuja, Nigeria., Palefsky JM; University of California, San Francisco, San Francisco, CA, USA., Adebajo S; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA; Institute of Human Virology Nigeria, Abuja, Nigeria., Tobin KE; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Gonzalez JM; Duke University School of Medicine, Durham, NC, USA., Nowak RG; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. |
